Medscape Conference Coverage, based on selected sessions at the:

Seventh Annual American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research

November 16 - 19, 2008; Washington, DC

This activity is not sanctioned by, nor a part of, the American Association for Cancer Research. Conference news does not receive grant support and is produced independently.

Conference News

  • Family History Increases Breast Cancer Risk

    Women with a significant family history of breast cancer have a 4-fold risk of developing the disease, even if they are negative for BRCA1/2 mutations.
    Medscape Medical News, November 26, 2008
  • ER/PR-Negative Breast Cancer

    Black women are more likely than white women to be diagnosed with estrogen- or progesterone-receptor-negative breast cancer, and differences in socioeconomic factors, stage at diagnosis, tumor size, and histology type accounts for about a third of this excess risk.
    Medscape Medical News, November 24, 2008
  • HIV Associated With Higher Risk for Cancer

    People infected with HIV have a higher rate of non-AIDS-defining cancers than the general population, and the underlying cause is believed to be multifactorial.
    Medscape Medical News, November 21, 2008
  • Cruciferous Vegetables Reduce Lung Cancer Risk

    The consumption of cruciferous vegetables could help reduce the risk for lung cancer in smokers.
    Medscape Medical News, November 20, 2008
  • Genetic Markers Identify Prostate Cancer Risk

    Five genetic risk markers might help identify men at the highest risk for a diagnosis of prostate cancer and help tailor and individualize screening.
    Medscape Medical News, November 19, 2008
  • Vitamins C and E Do Not Reduce Cancer Risk

    A large-scale prevention trial found that there is no beneficial effect of vitamin C or E supplementation on either prostate or overall cancer risk.
    Medscape Medical News, November 18, 2008
  • NSAIDs and Prostate Cancer Risk

    The use of aspirin and other nonsteroidal anti-inflammatory drugs is significantly associated with lower prostate-specific antigen levels, but it is unclear if they are having any effect on the development of prostate cancer.
    Medscape Medical News, November 18, 2008

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Association for Cancer Research. These materials and the related activity are not sanctioned by the American Association for Cancer Research or any commercial supporters of the conference and do not constitute an official part of that conference.